Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential (TRP) ion channels are a superfamily of non-selective cation channels that function as primary molecular sensors in sensory neurons, particularly within the dorsal root and trigeminal ganglia [PubMed: 29141514]. These channels, including key members such as TRPV1, TRPA1, and TRPM8, are responsible for detecting a diverse range of stimuli including noxious heat, extreme cold, mechanical pressure, and various chemical irritants [PubMed: 24560614]. Upon activation, TRP channels allow the influx of cations like calcium and sodium, leading to neuronal depolarization and the generation of action potentials that signal pain or thermal sensations to the central nervous system [PubMed: 11893340]. In pathological states, these channels can become hypersensitized or overexpressed, contributing significantly to chronic inflammatory and neuropathic pain [PubMed: 18039958]. Therapeutic strategies targeting TRP channels include the use of potent agonists to induce receptor desensitization and nerve terminal defunctionalization, as well as the development of small-molecule antagonists to block channel activation [PubMed: 17629561]. While drugs like topical capsaicin are clinically approved for pain management, the systemic use of TRP antagonists has faced challenges, most notably the occurrence of hyperthermia and the impairment of protective heat-pain thresholds [PubMed: 18039958].
Drugs targeting TRP channels primarily function as either agonists that cause receptor desensitization and temporary loss of sensory nerve function, or as antagonists that competitively or non-competitively inhibit channel opening to prevent signal transduction.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential ion channel (TRP channel) (TRP channel).